MedPath

Sodium Fluoride F 18

These highlights do not include all the information needed to use Sodium Fluoride F 18 Injection, USP safely and effectively. See full prescribing information for Sodium Fluoride F 18 Injection, USP. SODIUM FLUORIDE F 18 INJECTION, USPFor Intravenous UseInitial U.S. Approval: January 2011

Approved
Approval ID

4c45fe05-e3b7-4383-966c-4e218ff6f94a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 7, 2023

Manufacturers
FDA

Biomedical Research Foundation of Northwest Louisiana

DUNS: 184750008

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SODIUM FLUORIDE F-18

PRODUCT DETAILS

NDC Product Code24562-002
Application NumberANDA204351
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJanuary 14, 2015
Generic NameSODIUM FLUORIDE F-18

INGREDIENTS (2)

SODIUM FLUORIDE F-18Active
Quantity: 200 mCi in 1 mL
Code: 9L75099X6R
Classification: ACTIM
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Fluoride F 18 - FDA Drug Approval Details